The modulating actions of sulfonylurea on atrial natriuretic peptide release in experimental acute heart failure

European Journal of Heart Failure

Volumn 2, Issue 1, 2000, Pages 33-40

  Chen, Horng H ^a   Oh, Karen Y ^a   Terzic, Andre ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

ATP sensitive K+ channel; Cardioprotection; Kidney; Kir6.2; Natriuresis; Sulfonylurea

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLIBENCLAMIDE; POTASSIUM CHANNEL; PROTEIN SUBUNIT; SODIUM; SULFONYLUREA DERIVATIVE;

ACUTE HEART FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG MECHANISM; HEART LEFT ATRIUM PRESSURE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; DOGS; GLYBURIDE; HEART ATRIA; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HYPOGLYCEMIC AGENTS; KIDNEY; NATRIURESIS; POTASSIUM CHANNELS;

EID: 0034116286     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00074-4     Document Type: Article

References (36)

1. Loubatiere A. The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955. Ann NY Acad Sci. 71:1957;4-11.
2. ATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration [see comments]. Circulation. 94:1996;2297-2301.
3. Brady P.A., Terzic A. The sulfonylurea controversy - more questions from the heart. J Am Coll Cardiol. 31:1998;950-956.
4. Klimt C.R., Knatterud G.L., Meinert C.L., Prout T.E. A study of the effects of hypoglycemic agents in vascular complications in patients with adult-onset diabetes. Diabetes. 19:1970;747-830.
5. Garratt K.N., Brady P.A., Hassinger N.L., Grill D.E., Terzic A., Holmes D.R. Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 33:1999;119-124.
6. Ashcroft S., Ashcroft F.M. The sulfonylurea receptor. Biochem Biophys Acta. 1175:1992;45-59.
7. + channels in cardiac muscle by the sulfonylurea drug glibenclamide. J Pharmacol Exp Ther. 261:1992;540-545.
8. Brady P.A., Alekseev A.E., Terzic A. Operative condition-dependent response of cardiac KATP channels towards sulfonylureas. Circ Res. 82:1998;272-278.
9. ATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 270:1995;1166-1170.
10. + channels. Neuron. 16:1996;1011-1017.
11. Clement J.P., Kunjilwar K., Gonzalez G. et al. Association and stoichiometry of K-ATP channel subunits. Neuron. 18:1997;827-838.
12. + channel. Mol Cell Biol. 18:1998;1652-1659.
13. + channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol. 31:1999;425-434.
14. Gross G., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 70:1992;223-233.
15. + channels: regulation by intracellular nucleotides and potassium opening drugs. Am J Physiol. 38:1995;C525-C545.
16. Grover G.J. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol. 24:1994;S18-S27.
17. Gross G. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol. 90:1995;85-88.
18. ATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol. 264:1993;H495-H504.
19. Cleveland J.J., Meldrum D., Cain B., Banerjee A., Harken A. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation. 96:1997;29-32.
20. + channel subunits confer resistance towards chemical hypoxia-reoxygenation injury. Circulation. 98:1998;1548-1555.
21. Xu T., Jiao J.H., Pence R.A., Baertschi A.J. ATP-sensitive potassium channels regulate stimulated ANF secretion in isolated rat heart. Am J Physiol. 271:1996;H2339-H2345.
22. 2+ channel modulation. Eur J Physiol. 434:1997;362-372.
23. Burnett J.C. Jr., Kao P.C., Hu D.C. et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 231:1986;1145-1147.
24. Lee M.E., Miller W.M., Edwards B.S., Burnett J.C.J. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest. 84:1989;1962-1966.
25. Edwards B.S., Zimmerman R.S., Schwab T.R., Heublein D.M., Burnett J.C. Jr. Atrial stretch, not pressure, is the principle determinant controlling the acute release of atrial natriuretic factor. Clin Res. 62:1988;191-195.
26. Ruskoaho H., Vuolteenaho O. Regulation of atrial natriuretic peptide secretion. NIPS. 8:1993;261-266.
27. Stevens T.L., Rasmussen T.E., Wei C.M., Kinoshita M., Matsuda Y., Burnett J.C. Jr. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure. J Cardiac Failure. 2:1996;119-125.
28. Fett D.L., Cavero P.G., Burnett J.C. Jr. Low dose atrial natriuretic peptide and furosemide in experimental acute congestive failure. J Am Soc Nephrol. 4:1993;162-167.
29. Schultz J.E.J., Yao Z., Cavero I., Gross G.J. Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol. 272:1997;H2607-H2615.
30. Grantham J.A., Borgeson D.D., Burnett J.C. Jr. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol. 272:1997;R1077-R1083.
31. 2+ loading in cardiomyocytes. Eur J Pharmacol. 308:1996;343-349.
32. Heine R.J. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II - 'The cons'. Horm Metab Res. 28:1996;522-526.
33. Lopez M.J., Wong S.K.F., Kishimoto I. et al. Salt-resistant hypertension in mice lacking guanylyl cyclase - a receptor for atrial natriuretic peptide. Nature. 378:1995;65-68.
34. Sonnenberg H., Honrath U., Wilson D.R. In vivo microperfusion of inner medullary collecting duct in rats: effect of amiloride and ANF. Am J Physiol. 259:1990;F222-F226.
35. Clark M.A., Humphrey S.J., Smith M.P., Ludens J.H. Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats. J Pharmacol Exp Ther. 265:1993;933-937.
36. Van Wagoner D. Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res. 72:1993;973-983.